Aducanumab: A Deep Dive into BIIB037 and its Impact A drug, originally known as BIIB037, constitutes a complex endeavor to combat mild Alzheimer's condition. Developed by Biogen, aducanumab functions by removing https://www.targetmol.com/compound/aducanumab